Monday, June 28, 2021

PharmEasy gets $300 million booster shot for Thyrocare deal

PharmEasy has raised $300 million more, bringing the total funding received by the online pharmacy since April to $650 million, most of which will be used to fund its ongoing acquisition of diagnostics chain Thyrocare.

from Tech-Economic Times https://ift.tt/3Afitz4
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

MDR on UPI will hit businesses, not users: FM Nirmala Sitharaman hits back at Congress' Jairam Ramesh

Sitharaman accused the opposition leader of "spreading a canard" and clarified that MDR "applies only on the merchants and no...